SCHEMBL18504019

SCHEMBL18504019

c1ccc(-c2cc(-c3ccccc3)cc(-c3cccc(-c4cccc(-c5nc(-c6ccccc6-c6ccccc6)c6ccccc6n5)c4)c3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ ATM Q13315 2/20 0.48
▸ CYP1A2 P05177 6/20 0.43
▸ CYP3A4 P08684 5/20 0.43
▸ NR1I3 Q14994 4/20 0.43
▸ CYP2C9 P11712 4/20 0.43
▸ CYP2B6 P20813 2/20 0.43
▸ AHR P35869 2/20 0.43
▸ VDR P11473 1/20 0.43
▸ WHR1 P49842 1/20 0.41
▸ CYP2D6 P10635 3/20 0.40
▸ CYP2C19 P33261 3/20 0.40
▸ CLK4 Q9HAZ1 3/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ ADORA2A P29274 2/20 0.40
▸ ALDH1A1 P00352 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18503967 0.98 MEN1 (0.49) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL18504046 0.93 TGFBR1 (0.44) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL18503993 0.92 TGFBR1 (0.45) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL18504012 0.91 MEN1 (0.48) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL17412685 0.90 MEN1 (0.49) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL18504075 0.90 MEN1 (0.48) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL18504125 0.90 MEN1 (0.57) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL18503956 0.89 MEN1 (0.49) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL18504160 0.88 MEN1 (0.56) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL18504010 0.87 MEN1 (0.61) MEN1KMT2AATMCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 — — US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 — — US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 MEN1 1724/4885KMT2A 4198/4885ATM 4155/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 MEN1 1724/4885KMT2A 4198/4885ATM 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback